TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Study data from R. Walsh et al provide new insights into tuberculosis
September 23rd, 2008
In this recently published article, scientists in the United States conducted a study "To report our experience with fungal and mycobacterial (tuberculosis) infection following induction with Campath (alemtuzumab). We reviewed the database of 477 renal transplant patients induced with alemtuzumab." "All those who had a fungal or mycobacterial infection were found, and the details of these complications reviewed. Five patients were found to have fungal (3) or tuberculous (2) infection. The incidence of fungal infection was 0.6% and that of tuberculous infection was 0.4%. Mortality rates for these 2 types of infection were 50% and 100%, respectively. During the same...
Source: TB & Outbreaks Week (2008-09-23)
|
